Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome

Details for Australian Patent Application No. 2010213773 (hide)

Owner Cedars-Sinai Medical Center

Inventors Pimentel, Mark; Chang, Christopher

Agent Freehills

Pub. Number AU-A-2010213773

PCT Pub. Number WO2010/093776

Priority 61/151,772 11.02.09 US

Filing date 11 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/108 (2006.01) Medicinal preparations containing antigens or antibodies - Escherichia

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/093776 Priority application(s): WO2010/093776

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010213774-Methods of recovering hydrocarbons from hydrocarbonaceous material using a constructed infrastructure and associated systems maintained under positive pressure

2010213767-Secure payment and billing method using mobile phone number or account